OWC Pharmaceutical Research Competitors

OWC Pharmaceutical Research (OTCMKTS:OWCP) and Innovative Industrial Properties (NYSE:IIPR) are both miscellaneous companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations.

Profitability

This table compares OWC Pharmaceutical Research and Innovative Industrial Properties' net margins, return on equity and return on assets.

Insider & Institutional Ownership

74.9% of Innovative Industrial Properties shares are owned by institutional investors. 2.9% of Innovative Industrial Properties shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for OWC Pharmaceutical Research and Innovative Industrial Properties, as provided by MarketBeat.

Innovative Industrial Properties has a consensus price target of $192.4286, suggesting a potential upside of 1.82%. Given Innovative Industrial Properties' higher probable upside, analysts clearly believe Innovative Industrial Properties is more favorable than OWC Pharmaceutical Research.

Valuation & Earnings

This table compares OWC Pharmaceutical Research and Innovative Industrial Properties' top-line revenue, earnings per share (EPS) and valuation.

Innovative Industrial Properties has higher revenue and earnings than OWC Pharmaceutical Research.

Summary

Innovative Industrial Properties beats OWC Pharmaceutical Research on 8 of the 8 factors compared between the two stocks.

OWC Pharmaceutical Research (OTCMKTS:OWCP) and GrowGeneration (NASDAQ:GRWG) are both miscellaneous companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations.

Profitability

This table compares OWC Pharmaceutical Research and GrowGeneration's net margins, return on equity and return on assets.

Insider & Institutional Ownership

51.3% of GrowGeneration shares are owned by institutional investors. 13.6% of GrowGeneration shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for OWC Pharmaceutical Research and GrowGeneration, as provided by MarketBeat.

GrowGeneration has a consensus price target of $49.5714, suggesting a potential downside of 8.24%. Given GrowGeneration's higher probable upside, analysts clearly believe GrowGeneration is more favorable than OWC Pharmaceutical Research.

Valuation & Earnings

This table compares OWC Pharmaceutical Research and GrowGeneration's top-line revenue, earnings per share (EPS) and valuation.

GrowGeneration has higher revenue and earnings than OWC Pharmaceutical Research.

Summary

GrowGeneration beats OWC Pharmaceutical Research on 8 of the 8 factors compared between the two stocks.

OWC Pharmaceutical Research (OTCMKTS:OWCP) and 22nd Century Group (NYSEAMERICAN:XXII) are both miscellaneous companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations.

Profitability

This table compares OWC Pharmaceutical Research and 22nd Century Group's net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for OWC Pharmaceutical Research and 22nd Century Group, as provided by MarketBeat.

Valuation & Earnings

This table compares OWC Pharmaceutical Research and 22nd Century Group's top-line revenue, earnings per share (EPS) and valuation.

Summary

22nd Century Group beats OWC Pharmaceutical Research on 1 of the 1 factors compared between the two stocks.

OWC Pharmaceutical Research (OTCMKTS:OWCP) and KushCo (OTCMKTS:KSHB) are both miscellaneous companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for OWC Pharmaceutical Research and KushCo, as provided by MarketBeat.

KushCo has a consensus price target of $1.8750, suggesting a potential upside of 45.35%. Given KushCo's higher probable upside, analysts clearly believe KushCo is more favorable than OWC Pharmaceutical Research.

Valuation & Earnings

This table compares OWC Pharmaceutical Research and KushCo's top-line revenue, earnings per share (EPS) and valuation.

OWC Pharmaceutical Research has higher earnings, but lower revenue than KushCo.

Insider & Institutional Ownership

0.0% of KushCo shares are owned by institutional investors. 17.3% of KushCo shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares OWC Pharmaceutical Research and KushCo's net margins, return on equity and return on assets.

Summary

KushCo beats OWC Pharmaceutical Research on 5 of the 8 factors compared between the two stocks.

NSAV (OTCMKTS:NSAV) and OWC Pharmaceutical Research (OTCMKTS:OWCP) are both computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, valuation and institutional ownership.

Analyst Recommendations

This is a summary of recent ratings for NSAV and OWC Pharmaceutical Research, as reported by MarketBeat.com.

Earnings & Valuation

This table compares NSAV and OWC Pharmaceutical Research's gross revenue, earnings per share and valuation.

Profitability

This table compares NSAV and OWC Pharmaceutical Research's net margins, return on equity and return on assets.

Terra Tech (OTCMKTS:TRTC) and OWC Pharmaceutical Research (OTCMKTS:OWCP) are both industrial products companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, valuation and institutional ownership.

Analyst Recommendations

This is a summary of recent ratings for Terra Tech and OWC Pharmaceutical Research, as reported by MarketBeat.com.

Earnings & Valuation

This table compares Terra Tech and OWC Pharmaceutical Research's gross revenue, earnings per share and valuation.

OWC Pharmaceutical Research has lower revenue, but higher earnings than Terra Tech.

Insider & Institutional Ownership

0.1% of Terra Tech shares are owned by institutional investors. 6.7% of Terra Tech shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Profitability

This table compares Terra Tech and OWC Pharmaceutical Research's net margins, return on equity and return on assets.